We are live on ! Find out more
WVP

Worth Venture Partners Portfolio holdings

AUM $31.6M
1-Year Est. Return 28.5%
This Fund
S&P 500
This Quarter Est. Return
+12.98%
1 Year Est. Return
+28.5%
3 Year Est. Return
+102.5%
5 Year Est. Return
+128.77%
10 Year Est. Return
AUM
$206M
AUM Growth
+$80M
Cap. Flow
-$1.07M
Cap. Flow %
-0.52%
Top 10 Hldgs %
40.32%
Holding
148
New
41
Increased
22
Reduced
20
Closed
37

Sector Composition

Rank Sector Weight
1 Technology 20.62%
2 Healthcare 12.27%
3 Consumer Discretionary 3.1%
4 Financials 2.19%
5 Industrials 1.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HEPA
101
DELISTED
Hepion Pharmaceuticals
HEPA
-234
Closed -$512K
IPWR icon
102
Ideal Power
IPWR
$63.6M
-174,870
Closed -$1.43M
IWM icon
103
iShares Russell 2000 ETF
IWM
$81.5B
-5,211
Closed -$1.02M
KRG icon
104
Kite Realty
KRG
$5.69B
-13,457
Closed -$201K
KTCC icon
105
Key Tronic
KTCC
$42.8M
-12,590
Closed -$87K
MIRM icon
106
Mirum Pharmaceuticals
MIRM
$6.38B
-16,420
Closed -$287K
NDRA icon
107
ENDRA Life Sciences
NDRA
$5.31M
-9
Closed -$247K
PINE
108
Alpine Income Property Trust
PINE
$335M
-18,821
Closed -$282K
RCL icon
109
Royal Caribbean
RCL
$86.7B
-9,863
Closed -$737K
RIGL icon
110
Rigel Pharmaceuticals
RIGL
$693M
-17,781
Closed -$622K
VERI icon
111
PUT
Veritone
VERI
$103M
-14,600
Closed -$7K
VGT icon
112
Vanguard Information Technology ETF
VGT
$141B
-6,448
Closed -$285K
VNDA icon
113
Vanda Pharmaceuticals
VNDA
$315M
-89,124
Closed -$1.17M
XBI icon
114
State Street SPDR S&P Biotech ETF
XBI
$9.62B
-2,824
Closed -$398K
XLI icon
115
State Street Industrial Select Sector SPDR ETF
XLI
$33.3B
-2,626
Closed -$233K
XLV icon
116
State Street Health Care Select Sector SPDR ETF
XLV
$41.8B
-4,813
Closed -$546K
XLY icon
117
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$22.9B
-5,510
Closed -$443K
CYTH
118
DELISTED
Cyclo Therapeutics, Inc. Common Stock
CYTH
-88,690
Closed -$386K
PXD
119
DELISTED
Pioneer Natural Resource Co.
PXD
-3,489
Closed -$397K
BFX
120
DELISTED
BowFlex Inc.
BFX
-165,608
Closed -$3M
LTHM
121
PUT
DELISTED
Livent Corporation
LTHM
-10,300
Closed -$2K
ACER
122
DELISTED
Acer Therapeutics Inc
ACER
-250,518
Closed -$656K
NMTR
123
DELISTED
9 Meters Biopharma
NMTR
-39,467
Closed -$678K
CDR
124
DELISTED
Cedar Realty Trust, Inc
CDR
-11,055
Closed -$112K
OBCI
125
DELISTED
Ocean Bio-Chem Inc
OBCI
-156,274
Closed -$2.09M

Similar funds

Worth Venture Partners's Q1 2021 Portfolio in Review

As of Q1 2021, Worth Venture Partners held 148 positions worth $206M, up 63% from $126M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Worth Venture Partners's Q1 2021 filing shows 41 new, 22 increased, 20 reduced and 37 closed positions. Its largest new stake was Nuvve Holding Corp: 1 share worth $1.93M. The largest sale was Blue Bird Corp, an estimated $3.79M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Worth Venture Partners's largest Q1 2021 buy was Nuvve Holding Corp: 1 share worth $1.93M.
  • Worth Venture Partners added most to THERATECHNOLOGIES INC COM in Q1 2021, an estimated $2.73M increase.
  • Worth Venture Partners's biggest Q1 2021 reduction was Avaya Holdings Corp. Common Stock, cutting an estimated $2.03M.
  • Worth Venture Partners fully exited Blue Bird Corp in Q1 2021, selling an estimated $3.79M.
  • Worth Venture Partners's ten largest holdings make up 40% of its $206M portfolio in Q1 2021.
  • Worth Venture Partners opened 41 new positions and closed 37 in Q1 2021.
  • Worth Venture Partners's portfolio value rose 63% quarter-over-quarter to $206M.

Based on Worth Venture Partners's 13F filing for Q1 2021, filed 17 May 2021.